Blockchain Registration Transaction Record

OrthodontiCell Secures Funding for Phase II Pivotal Study of Bioelectric Tooth Movement Tech

OrthodontiCell secures capital for final testing of bioelectric tech to accelerate orthodontic tooth movement, advancing toward Phase II pivotal study.

This news matters because it brings the dental and orthodontic field one step closer to a potentially transformative treatment option. If successful, bioelectric technology could significantly reduce the duration of orthodontic treatment, which typically takes two years or more. Shorter treatment times would not only improve patient convenience and satisfaction but also could lead to better oral health outcomes due to improved compliance. For the estimated 4 million Americans who undergo orthodontic treatment annually, this technology could mean less time in braces or aligners, fewer office visits, and a faster path to a confident smile. Moreover, it represents a novel application of bioelectric stimulation in dentistry, opening doors for further innovations in regenerative and accelerated healing therapies. The funding milestone signals growing investor confidence in OrthodontiCell's approach and underscores the potential for non-invasive, drug-free solutions to common orthodontic challenges. As the company moves toward regulatory submission, the successful completion of this study could pave the way for a new standard of care in orthodontics.